Angy (China) Medical Limited CDI

A011.600
  • CHANGE
    0.00%
  • LAST
    1.6
  • VOLUME
    1600
  • LAST TRADE
    16-Feb-2021 1:00:02 PM

Annual Statements for Angy (China) Medical Limited (A01)

31-Dec
2020
31-Dec
2019
31-Dec
2018
31-Dec
2017
31-Dec
2016
HKD HKD HKD HKD HKD
REVENUE
Revenue from activities/operations102,805,227124,784,073111,256,56894,555,70689,213,655
Interest Received40,8296,8975,4538,5841,218
Grants96,33471810,381601,4431,448,869
Other Revenue775,89569,182411,763121,87032,433
Total Revenue103,718,285124,860,870111,684,16595,287,60390,696,175
Cost of sales
Cost of sales86,289,16199,207,14788,285,83572,600,02358,640,227
Total Cost of Sales86,289,16199,207,14788,285,83572,600,02358,640,227
Gross Profit17,429,12425,653,72323,398,33022,687,58030,573,428
EXPENSES
Administration Expenses(22,747,093)(20,201,930)(15,275,468)(15,624,927)(19,199,220)
Financing costs(117,066)(60,043)
Other Expenses(3,553,340)(6,732,249)(6,200,996)(5,440,206)(4,058,278)
Total Expenses(26,417,499)(26,994,222)(21,476,464)(21,065,133)(23,257,498)
PROFIT / (LOSS)
Profit/Loss before income tax(8,988,375)(1,263,702)1,921,8661,622,4478,798,450
Income tax/benefit expense258,122(384,103)(821,712)(273,083)(2,053,127)
Profit/Loss after income tax(8,730,253)(1,647,805)1,100,1541,349,3646,745,323
Total Comprehensive Income
ASSETS
Current Assets
Cash and Cash Equivalents2,550,7416,892,1854,800,6682,284,2275,408,139
Trade and Other Receivables11,856,0398,422,68616,960,78813,827,38313,428,919
Financial Assets1,180,383
Deferred Tax Assets114,61873,926362,675169,998125,455
Inventories15,433,72815,931,30821,791,97322,830,14325,227,103
Total Current Assets31,135,50931,320,10543,916,10439,111,75144,189,616
Non-Current Assets
Property, Plant and Equipment6,485,6083,742,176675,465352,159469,696
Financial Assets59,581
Goodwill155,639
Total Non-Current Assets6,545,1893,742,176675,465352,159625,335
Total Assets37,680,69835,062,28144,591,56939,463,91044,814,951
LIABILITIES
Current Liabilities
Trade and other payables12,794,9609,332,54616,431,31817,754,12320,782,998
Current Tax Liabilities194,561511,3491,083,4941,174,4961,219,013
Other Current liabilities8,520,1486,953,3766,078,3872,057,5995,499,657
Total Current Liabilities21,509,66916,797,27123,593,19920,986,21827,501,668
Non-Current Liabilities
Other Non-Current Liabilities60,926256,964
Total Non-Current Liabilities60,926256,964
Total Liabilities21,570,59517,054,23523,593,19920,986,21827,501,668
NET ASSETS16,110,10318,008,04620,998,37018,477,69217,313,283
EQUITY
Issued Capital10,000,00010,000,00010,000,00010,000,00010,000,000
Reserves2,925,1928,016,81410,613,5688,474,8536,750,552
Non-controlling interest3,184,911(8,768)384,8022,839562,731
Total Equity16,110,10318,008,04620,998,37018,477,69217,313,283
CASH FLOW
Net Cash provided by (used in) operating activities(1,892,255)6,523,2152,676,726(2,673,530)1,250,247
Net Cash provided by (used in) investing activities(6,112,735)5,863,6131,576,788(272,977)212,630
Net Cash provided by (used in) financing activities4,170,406(82,761)542,853
Net Increase (decrease) in cash held(4,431,831)2,745,1162,119,641(2,946,507)1,462,877
Foreign Exchange Gain/Loss90,387(653,599)396,800(177,405)(453,290)
Cash at the beginning of the period6,892,1854,800,6682,284,2275,408,1394,398,552
Cash at the end of the period2,550,7416,892,1854,800,6682,284,2275,408,139